                         SEQUENCE LISTING

<110>  University of Washington
 
<120>  Compositions and methods for Treating Dental Disorders and/or 
       Whitening Teeth

<130>  19-1363-PCT

<150>  US 62/725,160
<151>  2018-08-30

<150>  US 62/758,230
<151>  2018-11-08

<160>  34    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa can be L or I

<400>  1

His Thr Leu Gln Pro His His His Xaa Pro Val Val 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

His Thr Leu Gln Pro His His His Leu Pro Val Val 
1               5                   10          


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

His Thr Leu Gln Pro His His His Ile Pro Val Val 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa can be H or Q

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa can be T or I

<400>  4

Val Pro Gly Xaa His Ser Met Thr Pro Xaa Gln His 
1               5                   10          


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Val Pro Gly His His Ser Met Thr Pro Thr Gln His 
1               5                   10          


<210>  6
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Pro Gly Tyr Ile Asn Phe Ser Tyr Glu Asn Ser His Ser Gln Ala Ile 
1               5                   10                  15      


Asn Val Asp Arg Thr Ala 
            20          


<210>  7
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc
<222>  (3)..(3)
<223>  Xaa can be A or S

<400>  7

Trp Pro Xaa Thr Asp Lys Thr Lys Arg Glu Glu Val Asp 
1               5                   10              


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Trp Pro Ala Thr Asp Lys Thr Lys Arg Glu Glu Val Asp 
1               5                   10              


<210>  9
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Trp Pro Ser Thr Asp Lys Thr Lys Arg Glu Glu Val Asp 
1               5                   10              


<210>  10
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa can be S or T

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa can be L or I

<400>  10

His Pro Pro Xaa His Thr Leu Gln Pro His His His Xaa Pro Val Val 
1               5                   10                  15      


<210>  11
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

His Pro Pro Ser His Thr Leu Gln Pro His His His Leu Pro Val Val 
1               5                   10                  15      


<210>  12
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

His Pro Pro Thr His Thr Leu Gln Pro His His His Ile Pro Val Val 
1               5                   10                  15      


<210>  13
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa can be L or F

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa can be K or N

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa can be T or V

<400>  13

Pro Gly Tyr Ile Asn Xaa Ser Tyr Glu Xaa Ser His Ser Gln Ala Ile 
1               5                   10                  15      


Asn Xaa Asp Arg Thr Ala 
            20          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Val Pro Gly Gln His Ser Met Thr Pro Ile Gln His 
1               5                   10          


<210>  15
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa can be L or F

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa can be K or N

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa can be T or V

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa can be L or F

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  Xaa can be K or N

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa can be T or V

<400>  15

Pro Gly Tyr Ile Asn Xaa Ser Tyr Glu Xaa Ser His Ser Gln Ala Ile 
1               5                   10                  15      


Asn Xaa Asp Arg Thr Ala Pro Gly Tyr Ile Asn Xaa Ser Tyr Glu Xaa 
            20                  25                  30          


Ser His Ser Gln Ala Ile Asn Xaa Asp Arg Thr Ala 
        35                  40                  


<210>  16
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  16

Ser Tyr Glu Asn Ser His Ser Gln Ala Ile Asn Val Asp Arg Thr 
1               5                   10                  15  


<210>  17
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Leu Pro Pro Leu Phe Ser Met Pro Leu Ser Pro Ile Leu Pro Glu Leu 
1               5                   10                  15      


Pro Leu Glu Ala Trp Pro Ala Thr 
            20                  


<210>  18
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa can be S or T

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa can be L or I

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  Xaa can be A or I

<220>
<221>  MISC_FEATURE
<222>  (34)..(34)
<223>  Xaa can be H or Q

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  Xaa can be T or I

<400>  18

His Pro Pro Xaa His Thr Leu Gln Pro His His His Xaa Pro Val Val 
1               5                   10                  15      


Pro Ala Gln Gln Pro Val Xaa Pro Gln Gln Pro Met Met Pro Val Pro 
            20                  25                  30          


Gly Xaa His Ser Met Thr Pro Xaa Gln His 
        35                  40          


<210>  19
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  19

His Pro Pro Ser His Thr Leu Gln Pro His His His Leu Pro Val Val 
1               5                   10                  15      


Pro Ala Gln Gln Pro Val Ala Pro Gln Gln Pro Met Met Pro Val Pro 
            20                  25                  30          


Gly His His Ser Met Thr Pro Thr Gln His 
        35                  40          


<210>  20
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

His Pro Pro Thr His Thr Leu Gln Pro His His His Ile Pro Val Val 
1               5                   10                  15      


Pro Ala Gln Gln Pro Val Ile Pro Gln Gln Pro Met Met Pro Val Pro 
            20                  25                  30          


Gly Gln His Ser Met Thr Pro Ile Gln His 
        35                  40          


<210>  21
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa can be A or I

<400>  21

Pro Ala Gln Gln Pro Val Xaa Pro Gln Gln Pro Met Met Pro 
1               5                   10                  


<210>  22
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  22

Pro Ala Gln Gln Pro Val Ala Pro Gln Gln Pro Met Met Pro 
1               5                   10                  


<210>  23
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  23

Pro Ala Gln Gln Pro Val Ile Pro Gln Gln Pro Met Met Pro 
1               5                   10                  


<210>  24
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  24

Ser Tyr Glu Lys Ser His Ser Gln Ala Ile Asn Thr Asp Arg Thr 
1               5                   10                  15  


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  25

Met Leu Pro His His Gly Ala 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  26

Asn Pro Gly Phe Ala Gln Ala 
1               5           


<210>  27
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  27

Lys Trp Lys Arg Trp Trp Trp Trp Arg 
1               5                   


<210>  28
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  28

Leu Lys Leu Leu Lys Lys Leu Leu Lys Leu Leu Lys Lys Leu 
1               5                   10                  


<210>  29
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  29

Cys Pro Phe Val Cys 
1               5   


<210>  30
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (3)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  30

Arg Arg Xaa Xaa Arg Phe 
1               5       


<210>  31
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  31

Ala Leu Leu His His Gly Leu Asn Cys Ala Lys Gly Val Leu Ala 
1               5                   10                  15  


<210>  32
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  32

Leu Trp Lys Thr Leu Leu Lys Lys Val Leu Lys Ala Ala Ala 
1               5                   10                  


<210>  33
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  33

Gly Leu Arg Lys Arg Lys Arg Lys Phe Arg Asn Lys Lys Lys Glu Lys 
1               5                   10                  15      


Leu Lys Lys Ile 
            20  


<210>  34
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  34

Arg Lys Arg Ile His Ile Gly Pro Gly Arg Ala Phe Tyr Thr Thr 
1               5                   10                  15  


